Kisspeptin-54 vs Cetrorelix
Head-to-head comparison of Kisspeptin-54 (Kisspeptin-54 (metastin), 54-amino-acid KISS1 peptide fragment) and Cetrorelix (Cetrorelix acetate) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Kisspeptin-54 | Cetrorelix |
|---|---|---|
| Category | Sexual Health | Sexual Health |
| Full Name | Kisspeptin-54 (metastin), 54-amino-acid KISS1 peptide fragment | Cetrorelix acetate |
| Molecular Weight | 5.9 kDa | 1431.06 Da |
| Half-Life | about 20-30 min | ~30 hours |
| Amino Acids | 54 | 10 |
| Typical Dose | 0.3-1.0 nmol/kg | 0.25 mg SC daily |
| Route | Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 110 | 300 |
| Research Status | Clinical | Clinical |
Kisspeptin-54 Benefits
- ✓GnRH/LH stimulation
- ✓supports sex hormone signaling
- ✓may enhance sexual motivation
- ✓fertility-axis modulation
Cetrorelix Benefits
- ✓prevents premature ovulation
- ✓supports IVF cycle control
- ✓blocks LH surge
- ✓short-acting pituitary suppression
Kisspeptin-54 Dosing
0.3-1.0 nmol/kg IV bolus|single-dose experimental protocols|research-only endocrine monitoring
Cetrorelix Dosing
0.25 mg SC daily|start on stimulation day 5-6|protocol-dependent antagonist cycle
Kisspeptin-54 Side Effects
- ⚠flushing
- ⚠nausea
- ⚠headache
- ⚠hormonal shifts
Cetrorelix Side Effects
- ⚠injection-site reactions
- ⚠headache
- ⚠nausea
Research Overview
Kisspeptin-54
Human studies show that kisspeptin-54 can acutely modulate reproductive neuroendocrine signaling, which makes it relevant to libido and sexual motivation research. Its effects are indirect compared with PT-141, but it is a well-established peptide in the scientific literature.
Cetrorelix
Cetrorelix is a cornerstone GnRH antagonist in assisted reproduction, with a fast onset and reversible suppression of LH. Trials show it improves cycle management by reducing premature ovulation during stimulation.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.